ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

FENC Fennec Pharmaceuticals Inc

9,23
0,13 (1,43%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Fennec Pharmaceuticals Inc FENC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,13 1,43% 9,23 00:00:52
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
9,23 9,15 9,38 9,23 9,10
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
21.3.202411:00GLOBEFennec Pharmaceuticals Reports Full Year and Fourth Quarter..
19.3.202411:01GLOBEFennec Pharmaceuticals to Report Full Year and Fourth..
18.3.202408:00PRNUSFennec Pharmaceuticals and Norgine Enter into Exclusive..
18.3.202402:00GLOBEFennec Pharmaceuticals and Norgine Enter into Exclusive..
06.3.202422:07EDGAR2Form 8-K/A - Current report: [Amend]
29.2.202422:04EDGAR2Form 8-K - Current report
29.2.202413:04GLOBEFennec Pharmaceuticals Reports Preliminary Unaudited Net..
14.2.202416:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01.2.202411:55GLOBEFDA Issues Reminder of Non-Substitution of PEDMARK® (sodium..
05.1.202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202422:45EDGAR2Form 144 - Report of proposed sale of securities
04.1.202422:42EDGAR2Form 144 - Report of proposed sale of securities
29.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202321:51EDGAR2Form 144 - Report of proposed sale of securities
18.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
05.12.202311:55GLOBEFennec Announces Incremental $5 Million Investment from..
16.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202322:56EDGAR2Form S-3 - Registration statement under Securities Act of..
09.11.202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:50GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
09.11.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:19EDGAR2Form 144 - Report of proposed sale of securities
06.11.202311:59GLOBEFennec Pharmaceuticals Announces Third Quarter 2023..
03.11.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202311:45GLOBEFennec Pharmaceuticals to Report Third Quarter 2023..
07.9.202311:59GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
07.8.202323:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.8.202316:51EDGAR2Form 8-K/A - Current report: [Amend]
04.8.202316:58EDGAR2Form 8-K - Current report
04.8.202316:57EDGAR2Form 8-K - Current report
03.8.202311:59GLOBEFennec Pharmaceuticals Announces Second Quarter 2023..
31.7.202311:30GLOBEFennec Pharmaceuticals to Report Second Quarter 2023..
30.6.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.6.202323:00GLOBEFennec Announces Results of Annual Meeting
06.6.202311:44GLOBEFennec Pharmaceuticals Announces European Commission..
11.5.202312:01GLOBEFennec Pharmaceuticals Announces First Quarter 2023..
08.5.202312:15GLOBEFennec Pharmaceuticals to Report First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock